Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy

Locally advanced hepatocellular carcinoma (HCC) with portal vein thrombosis carries a 1-year survival rate <10%. Localized concurrent chemoradiotherapy (CCRT), followed by hepatic arterial infusion chemotherapy (HAIC), was recently introduced in this setting. Here, we report our early experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Dai Hoon, Joo, Dong Jin, Kim, Myoung Soo, Choi, Gi Hong, Choi, Jin Sub, Park, Young Nyun, Seong, Jinsil, Han, Kwang-Hyub, Kim, Soon Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960397/
https://www.ncbi.nlm.nih.gov/pubmed/27401662
http://dx.doi.org/10.3349/ymj.2016.57.5.1276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960397/
https://www.ncbi.nlm.nih.gov/pubmed/27401662
http://dx.doi.org/10.3349/ymj.2016.57.5.1276

Ejemplares similares